Actively Recruiting
Safety and Effectiveness of a Triple-branched Stent Graft for Arch Repair During Open Acute Debakey Type I Dissection Surgery - a Randomized Controlled Multicenter Clinical Trial
Led by Fujian Medical University · Updated on 2024-07-09
150
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate the effectiveness and safety of a new intraoperative stent system for treating acute type I aortic dissection, a serious condition where the inner layer of the aorta tears, causing life-threatening complications. This type involves the ascending aorta, aortic arch, and the entire aorta, and surgery is currently the only treatment option. The study compares this new stent system with the existing Frozen Elephant Trunk Technique to improve long-term outcomes by better reconstructing the aortic arch and preventing complications from residual false lumens. The study involves two groups: one receiving the new triple-branched stent graft implanted directly into the aortic arch and its branches during surgery, and the other undergoing the standard procedure of ascending aorta and arch replacement with the Frozen Elephant Trunk stent placed in the descending thoracic aorta. The new stent system aims to simplify surgery by reducing the need for multiple anastomoses and shortening the time of cerebral and lower body ischemia. Participants will be closely monitored through various assessments during and after surgery, including mortality within 30 days as the primary outcome. Secondary outcomes include death related to aortic dissection within 12 months, thrombosis of the false lumen, and technical success of the procedure. Follow-up will last up to one year to evaluate safety and effectiveness. The total study duration for each participant depends on surgical and follow-up schedules, with careful data collection at multiple time points.
CONDITIONS
Brief Title
A Triple-branched Stent Graft for Aute Debakey Type I Dissection Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with acute type I aortic dissection who need arch repair
- Aged 20 years to 65 years
- Acute phase with onset within 14 days before surgery
- Able to understand the trial purpose, voluntarily participate, sign informed consent, and accept follow-up
You will not qualify if you...
- Anatomical variations like aortic arch malformation, aortic coarctation, or abnormal branch artery origins
- Dissection secondary to previous aortic treatment or Marfan syndrome
- Aortic lesions causing severe ischemic complications such as myocardial ischemia, stroke, paraplegia, mesenteric artery ischemia, or renal artery dysplasia
- Uncontrolled severe infections
- Need for other serious concomitant treatments for conditions like severe hypertension or chronic kidney disease
- Life-threatening diseases with expected survival less than one year, such as advanced malignant tumors
- Other heart or aortic diseases requiring concurrent surgery or unsuitable for stent treatment
- Participation in other drug or device clinical trials without reaching primary endpoint
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Acute phase with onset within 14 days before surgery
Participants undergo surgery to repair acute type I aortic dissection using either a triple-branched stent graft or an aortic arch replacement with frozen elephant trunk technique.
1 surgery visit (in-person)
Duration - Up to 12 months after surgery
Participants are monitored for safety and effectiveness outcomes including mortality and thrombosis in the false lumen after surgery.
Regular follow-up visits during 12 months
Trial Site Locations
Total: 1 location
1
Department of Cardiovascular Surgery
Fuzhou, Fujian, China, 350001
Actively Recruiting
Research Team
L
Liang-wan Chen, M.D Ph.D
X
Xiao-fu Dai, M.D Ph.D
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here